Hjertholm, P., Fenger-Grøn, M., Vestergaard, M., Christensen, M. B., Borre, M., Møller, H. & Vedsted, P. (2015).
Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: An ecological study.
International Journal of Cancer.
https://doi.org/10.1002/ijc.29008
Nordentoft, I. K., Lamy, P., Birkenkamp-Demtröder, K., Shumansky, K.
, Vang, S., Hornshøj, H., Juul, M., Villesen, P., Hedegaard, J., Roth, A.
, Thorsen, K., Høyer, S., Borre, M., Reinert, T., Fristrup, N., Dyrskjøt, L., Shah, S.
, Pedersen, J. S. & Ørntoft, T. F. (2014).
Mutational context and diverse clonal development in early and late bladder cancer: Genomic changes in bladder cancer.
Cell Reports,
7(5), 1649–1663.
https://doi.org/10.1016/j.celrep.2014.04.038
van Rijt, W. G.
, Secher, N., Keller, A. K., Møldrup, U., Chynau, Y., Ploeg, R. J., van Goor, H.
, Nørregaard, R., Birn, H., Frøkiaer, J., Nielsen, S., Leuvenink, H. G. D.
& Jespersen, B. (2014).
α-Melanocyte Stimulating Hormone Treatment in Pigs Does Not Improve Early Graft Function in Kidney Transplants from Brain Dead Donors.
PLOS ONE,
9(4), e94609.
https://doi.org/10.1371/journal.pone.0094609
Kristensen, H., Haldrup, C., Strand, S., Mundbjerg, K., Mortensen, M. M., Thorsen, K., Ostenfeld, M. S., Wild, P. J., Arsov, C., Goering, W., Visakorpi, T., Egevad, L., Lindberg, J., Grönberg, H.
, Høyer, S., Borre, M., Orntoft, T. F. & Sørensen, K. D. (2014).
Hypermethylation of the GABRE~miR-452~miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy.
Clinical Cancer Research,
20(8), 2169-81.
https://doi.org/10.1158/1078-0432.CCR-13-2642
Wagenlehner, F., van Oostrum, E., Tenke, P., Tandogdu, Z., Cek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., Weidner, W.
& Johansen, T. E. B. (2013).
Reply from Authors re.: Riccardo Bartoletti, Tommaso Cai.Prostate Biopsies Should Be Performed According to a Standard of Care.
European Urology,
63(3), 529-30. Article 63, 3.
https://doi.org/10.1016/j.eururo.2012.07.037
Wagenlehner, F. M. E., van Oostrum, E., Tenke, P., Tandogdu, Z., Çek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., Weidner, W.
, Johansen, T. E. B. & GPIU investigators (2013).
Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.
European Urology,
63(3), 521-7.
https://doi.org/10.1016/j.eururo.2012.06.003
Cockle-Hearne, J., Charnay-Sonnek, F., Denis, L., Fernandez-Ortega, P., Kav, S., Kelly, D., Leonard, K., Van Muilekom, E.
, Jensen, B. T. & Faithfull, S. (2013).
Supportive care needs of men with prostate cancer: A european survey for the prostate cancer education project (PrEP).
European Journal of Oncology Nursing, 14-15. Article vol. 16, suppl.
Røder, M. A., Brasso, K., Christensen, I. J., Johansen, J.
, Langkilde, N. C., Hvarness, H., Carlsson, S., Jakobsen, H.
, Borre, M. & Iversen, P. (2013).
Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study.
B J U International (Print).
https://doi.org/10.1111/bju.12065
Jespersen, C. G., Nørgaard, M., Friis, S., Skriver, C.
& Borre, M. (2013).
Statin use and risk of prostate cancer: A Danish population-based case-control study, 1997-2010.
Cancer epidemiology,
38(1), 42-7.
https://doi.org/10.1016/j.canep.2013.10.010
Thomsen, F. B., Røder, M. A., Rathenborg, P., Brasso, K.
, Borre, M. & Iversen, P. (2013).
Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate.
Scandinavian Journal of Urology and Nephrology.
https://doi.org/10.3109/21681805.2013.860189